Want to support Global Action on Aging? Click below: Thanks! |
Medicare bill would require co-pays for
seniors' lab tests
By Susan Jaffe and Stephen Koff
Congress wants to add
prescription drug coverage to Medicare, but it also might trim a benefit
that could cost seniors billions of dollars. Buried deep inside the hundreds
of pages of the Senate's Medicare bill is a provision requiring Medicare
patients to pay 20 percent of the costs of their clinical lab work, such as
blood tests and urinalysis. Seniors would have to start paying in January. Some physicians predicted many of
their patients would be unable to pay the new fees and wouldn't get the
tests they need. "Every time you add
co-payments, you limit service for people who can't afford it," said
Dr. Peter DeGolia, medical director for long-term services at Metro Health
Medical Center. "It's an other way of rationing care." The Senate measure, now being
reconciled with the House version, would reverse a 1984 decision in which
doctors, hospitals and labs agreed, with a nod from Congress, not to charge
patients co-payments for lab tests. Fees for blood tests to check
cholesterol levels, electrolytes for dehydration and glucose for diabetes
and to make dozens of other checks for chemicals, anti bodies or bacteria
typically run $25 to $40, said Mark Birenbaum, a microbiologist. Birenbaum is the administrator of
the American Association of Bioanalysts. Nationwide, the co-payments could
total $18.6 billion over the next 10 years, said the Clinical Laboratory
Coalition, which is campaigning against the provision. Co-payments for seniors on
Medicare, the health insurance plan for 40 million elderly and disabled
Americans, would be $5 to $8 a test. But seniors who need regular
tests could quickly see those fees add up. "Medicare is supposed to be
helping us, but we're paying more and more out of our own pockets,"
said Anne McKinley, 78, who lives in Lake County. "Somewhere it has to
stop." Blood tests are especially
important to monitor the condition of older patients, who are more likely to
have multiple chronic health problems, said Dr. Robert Palmer, director of
geriatric medicine at the Cleveland Clinic. The tests can detect adverse side
effects of the many medications older patients rely on. "There's a rational reason
for these tests," he said. "I might as well be practicing in a
jungle if I don't have a laboratory." In the case of about 185,000
low-income Ohio seniors who are also covered by Medicaid, the state-run
program for the poor, the state would have to make the new co-payments. The prospect of additional
expenses worries state officials struggling to keep up with rising
health-care costs. Medicaid is already the fastest-
growing portion of the state bud get, and program officials have been
looking for ways to cut costs, said Dennis Evans, a spokesman for the Ohio
Department of Job & Family Services, which runs the Medicaid pro gram. "If we're required to do it,
we've got to come up with the money," he said. Bill Hoagland, director of bud
get and appropriations for Sen ate Majority Leader Bill Frist, Re publican
of Tennessee, said the co-payments would provide money to help pay for other
benefits for seniors. But Robert Hayes of the Medicare
Rights Center said, "It obviously defeats the purpose of pro viding a
drug benefit if you pay for it by picking the pockets of senior
citizens." The House version of the Medicare
prescription-drug bill, which like the Senate bill also passed last week,
does not contain that provision. Lawmakers will start resolving differences between the two bills this month. But senior staffers in both chambers don't expect a final bill to be ready for a vote until fall. Copyright ©
2002 Global Action on Aging
|